BCRX
Biocryst Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.22
-0.16 ▼ -1.91%
🌙 3월 13일 7:38 PM ET (한국 3/14 08:38)
$8.15
-0.07 ▼ -0.85%
| Index | RUT | P/E | 6.83 | EPS (ttm) | 1.2 | Insider Own | 8.2% | Shs Outstand | 0.25B | Perf Week | -3.07% |
| Market Cap | 2.06B | Forward P/E | 17.4 | EPS next Y | 72.11% | Insider Trans | -1.03% | Shs Float | 0.23B | Perf Month | 20.18% |
| Enterprise Value | 2.26B | PEG | - | EPS next Q | 0.05 | Inst Own | 77.18% | Short Float | 17.55% | Perf Quarter | 7.31% |
| Income | 0.26B | P/S | 2.36 | EPS this Y | -77.31% | Inst Trans | -1.47% | Short Ratio | 9.04 | Perf Half Y | 1.86% |
| Sales | 0.87B | P/B | - | EPS next 5Y | -27.57% | ROA | 52.53% | Short Interest | 40.42M | Perf YTD | 5.38% |
| Book/sh | -0.56 | P/C | 7.5 | EPS past 3/5Y | - | ROE | - | 52W High | -27.32% ($11.31) | Perf Year | 9.02% |
| Cash/sh | 1.1 | P/FCF | 6.3 | Sales past 3/5Y | 47.82% 117.89% | ROIC | 82.95% | 52W Low | 37% ($6.00) | Perf 3Y | -1.08% |
| Dividend Est. | - | EV/EBITDA | 6.61 | EPS Y/Y TTM | 390.89% | Gross Margin | 97.66% | Volatility(W/M) | 3.76% 4.13% | Perf 5Y | -34.97% |
| Dividend TTM | - | EV/Sales | 2.59 | Sales Y/Y TTM | 94.1% | Oper. Margin | 38.98% | ATR (14) | 0.33 | Perf 10Y | 190.46% |
| Dividend Ex-Date | - | Quick Ratio | 2.03 | EPS Q/Q | 967.8% | Profit Margin | 30.16% | RSI (14) | 57.61 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.06 | Sales Q/Q | 209.09% | SMA20 | 2.35% ($8.03) | Beta | 0.77 | Target Price | $21.3 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | 11.8% ($7.35) | Rel Volume | 1.23 | Prev Close | $8.38 |
| Employees | 435 | LT Debt/Eq | - | EPS/Sales Surpr. | 2218.84% 168.66% | SMA200 | 3.14% ($7.97) | Avg Volume(3M) | 4.47M | Price | $8.22 |
| IPO | 1994/3/4 | Option/Short | Yes/Yes | Trades | 15738 | Volume | 5,516,666 | Change | -1.91% |
뉴스 로딩 중...